Back to Search
Start Over
Supplemental Table 1 from AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental Table 1. Quantification of ENPP3 Expression in Various Carcinomas
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....81085b4cbfb6ad90b94dc083d54e1849
- Full Text :
- https://doi.org/10.1158/1078-0432.22460334